Subscribe
home
leadership
innovation
billionaires
startups
AI Tracker
Lists
30 Under 30 2026
India Rich List 2025
AI Special 2025
W Power 2025
30 Under 30 2025
India Rich List 2024
Digital Stars 2024
All Lists
Podcasts
To The Point
Tech Conversations
Money Talks
Startup Fridays
From the Bookshelves
All Podcasts
Videos
Leadership Mantras
Pathbreakers
Lets Talk About
One Thing Today in Tech
Momentum
Nuts and Bolts
In Conversation With
From the Field
Beyond the Boardroom
All Videos
Magazine
More
Cover Stories
News
Life
Thought Leadership
Blogs
Photo Galleries
Photo Features
3sbio
All
Articles
Videos
Podcasts
Blogs
Advertisement
3SBio: Firm hold over biopharma
The drugmaker has gotten a big foothold in China and wants future breakthroughs to be global
By
Jane Ho
Forbes India Newsletters
Stay ahead of the curve with access to our Curated, handpicked content
Subscribe Now
By signing up, you agree to our
Terms and Conditions
( including the class action waiver and arbitration provisions ) and
Privacy Policy
.
Explore More Tags
international-monetary-fund
(2)
bharatiya-janata-party
(1)
chips-and-science-act
(1)
donald-trump
(1)
elon-musk
(1)
infosys
(1)
larry-ellison
(1)
microsoft
(1)
narendra-modi
(1)
national-stock-exchange
(1)
Home
/
3sbio
Subscribe Now
Latest News
Infosys Q3 results: Steady growth even as margins hit by labour code reforms
By
Naini Thaker
AlphaBots Analytics: Building institutional-grade trading infrastructure for Ind
By
Brand Connect
US Supreme Court skips tariff ruling again: Highlights
By
Vasudha Mukherjee,
Samreen Wani
With 10-min tagline gone, will quick commerce face a branding rethink?
By
Naini Thaker
Rethinking organisational well-being
By
INSEAD
Stay the Raho way: A new blueprint for India’s homestays
By
Pankti Mehta Kadakia
Advertisement
Advertisement
Advertisement
